Article
A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
The Journal of biological chemistry - 15 Feb 2002
Miyamoto Hiroshi, Rahman Mujib, Takatera Hiroshi, Kang Hong-Yo, Yeh Shuyuan, Chang Hong-Chiang, Nishimura Kazuo, Fujimoto Naohiro, Chang Chawnshang
Abstract excerpt
The ligand-bound androgen receptor (AR) regulates target genes via a mechanism involving coregulators such as androgen receptor-associated 54 (ARA54). We investigated whether the interruption of the AR coregulator function could lead to down-regulation of AR activity. Using in vitro mutagenesis and a yeast two-hybrid screening assay, we have isolated a mutant ARA54 (mt-ARA54) carrying a point mutation at amino...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
